(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Cervical Dysplasia
This study will evaluate the effectiveness of an investigational gel applied intravaginally in clearing HPV infection. Candidates must be women between 18 and 40, willing to be on an acceptable method of birth control, having a screening pap test of low-grade squamous intraepithelial lesions (LSIL) or atypical squamous cells of undetermined significance (ASC-US), and being high risk HPV positive. Participants cannot have a history of bleeding disorder, toxic shock syndrome, or be HIV positive.
Research sites are located in Alabama, Michigan, and Pennsylvania.
More information
Please see http://www.centerwatch.com/patient/studies/cat395.html.
-----
High Cholesterol (Hyperlipidemia)
This trial will evaluate an investigational medication to reduce cholesterol in people with hyperlipidemia. Candidates will receive at no cost study related medical evaluations, lab testing, physical examinations, and study related medications. Participants also may be compensated for time and travel.
The research site is in Cincinnati, Ohio.
More information
Please see http://www.centerwatch.com/patient/studies/cat170.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
